These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36741198)

  • 1. The effect of sodium benzoate, L-carnitine, and phenylacetate on valproate-induced hyperammonemia in Male Wistar rats.
    Etemad L; Roohbakhsh A; Abbaspour A; Alizadeh Ghamsari A; Amin F; Moshiri M
    Int J Physiol Pathophysiol Pharmacol; 2022; 14(6):324-331. PubMed ID: 36741198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of sodium phenylacetate and sodium benzoate following intravenous administration as both a bolus and continuous infusion to healthy adult volunteers.
    MacArthur RB; Altincatal A; Tuchman M
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S67-73. PubMed ID: 15050977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saline is as effective as nitrogen scavengers for treatment of hyperammonemia.
    van Straten G; de Sain-van der Velden MGM; van Geijlswijk IM; Favier RP; Mesu SJ; Holwerda-Loof NE; van der Ham M; Fieten H; Rothuizen J; Spee B; Verhoeven-Duif NM
    Sci Rep; 2017 Oct; 7(1):13112. PubMed ID: 29030642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine.
    O'Connor JE; Costell M; Grisolía S
    Biochem Biophys Res Commun; 1987 Jun; 145(2):817-24. PubMed ID: 3593373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate].
    Michalak A; Qureshi IA
    Can J Physiol Pharmacol; 1993 Jul; 71(7):439-46. PubMed ID: 8242478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waste nitrogen excretion via amino acid acylation: benzoate and phenylacetate in lysinuric protein intolerance.
    Simell O; Sipilä I; Rajantie J; Valle DL; Brusilow SW
    Pediatr Res; 1986 Nov; 20(11):1117-21. PubMed ID: 3099249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
    Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
    N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts.
    van Straten G; van Dalen D; Mesu SJ; Rothuizen J; Teske E; Spee B; Favier RP; van Geijlswijk IM
    J Vet Intern Med; 2019 May; 33(3):1331-1335. PubMed ID: 30916412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status.
    Hamed SA; Abdella MM
    Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The problems of valproate therapy in severely handicapped children--valproate induced hyperammonemia and hypocarnitinemia].
    Matsui K; Iwamoto H; Ohtsuki N; Kobayashi T; Miyake S; Yamada M
    No To Hattatsu; 1991 Jan; 23(1):32-8. PubMed ID: 1825272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of D,L-carnitine on valproate-induced hyperammonemia and hypoketonemia in primary cultured rat hepatocytes.
    Takeuchi T; Sugimoto T; Nishida N; Kobayashi Y
    Biochem Pharmacol; 1988 Jun; 37(11):2255-8. PubMed ID: 3132174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report.
    Mehta S; Tayabali S; Lachmann R
    J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sudden valproate-induced hyperammonemia managed with L-carnitine in a medically healthy bipolar patient: Essential review of the literature and case report.
    Cattaneo CI; Ressico F; Valsesia R; D'Innella P; Ballabio M; Fornaro M
    Medicine (Baltimore); 2017 Sep; 96(39):e8117. PubMed ID: 28953637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-Carnitine supplementation to reverse hyperammonemia in a patient undergoing chronic valproic acid treatment: A case report.
    Maldonado C; Guevara N; Silveira A; Fagiolino P; Vázquez M
    J Int Med Res; 2017 Jun; 45(3):1268-1272. PubMed ID: 28425821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salicylate potentiates valproate-induced hyperammonemia in the rat.
    Uetrecht JP
    Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of carglumic acid in valproate-induced hyperammonemia: 25 pediatric cases.
    Palomino Pérez LM; Martín-Rivada Á; Cañedo Villaroya E; García-Peñas JJ; Cuervas-Mons Vendrell M; Pedrón-Giner C
    JIMD Rep; 2020 Sep; 55(1):3-11. PubMed ID: 32905024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemia.
    Stravitz RT; Gottfried M; Durkalski V; Fontana RJ; Hanje AJ; Koch D; Hameed B; Ganger D; Subramanian RM; Bukofzer S; Ravis WR; Clasen K; Sherker A; Little L; Lee WM;
    Hepatology; 2018 Mar; 67(3):1003-1013. PubMed ID: 29080224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Arginine in the treatment of valproate overdose - five clinical cases.
    Schrettl V; Felgenhauer N; Rabe C; Fernando M; Eyer F
    Clin Toxicol (Phila); 2017 Apr; 55(4):260-266. PubMed ID: 28152637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.